The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Open accessAbstract
There is considerable confusion over the management of Helicobacter pylori infection, particularly among primary care physicians, and numerous European countries lack national guidelines in this rapidly growing area of medicine. The European Helicobacter Pylori Study Group therefore organised a meeting in Maastricht of H pylori experts, primary care physicians and representatives of National Societies of Gastroenterology from Europe to establish consensus guidelines on the management of H pylori at the primary care and specialist levels, and to consider general health care issues associated with the infection. As in previous guidelines, eradication therapy was recommended in all H pylori positive patients with peptic ulcer disease. Additionally, at the primary care level in dyspeptic patients < 45 years old and with no alarm symptoms, diagnosis is recommended by non-invasive means (13C urea breath test, serology) and if H pylori positive the patient should be treated. Moreover, at the specialist level the indications for eradication of H pylori were also broadened to include H pylori positive patients with functional dyspepsia in whom no other possible causes of symptoms are identified by the specialist (after a full investigation including endoscopy, ultrasound and other necessary investigations), patients with low grade gastric mucosa associated lymphoid tissue (MALT) lymphoma (managed in specialised centres) and those with gastritis with severe macro- or microscopic abnormalities. There was consensus that treatment regimens should be simple, well tolerated and achieve an eradication rate of over 80% on an intention to treat basis. It was strongly recommended, therefore, that eradication treatment should be with proton pump inhibitor based triple therapy for seven days, using a proton pump inhibitor and two of the following: clarithromycin, a nitroimidazole (metronidazole or tinidazole) and amoxycillin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., Havu, N., Festen, H. P. M., Liedman, B., Lamers, C. B. H. W., Jansen, J. B. M. J., Dalenbäck, J., Snel, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341603 · Cited by 769
Hopkins, R., Girardi, L., & Turney, E. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613015 · Cited by 574
Lind, T., van Zanten, S. V., Unge, P., Spiller, R., Bayerdörffer, E., O'Morain, C., Bardhan, K. D., Bradette, M., Chiba, N., Wrangstadh, M., et al. (1996) · Helicobacter · doi:10.1111/j.1523-5378.1996.tb00027.x · Cited by 573
Treatment of Helicobacter pylori Reduces the Rate of Rebleeding in Peptic Ulcer Disease
Graham, D. Y., Hepps, K. S., Ramirez, F. C., Lew, G. M., & Saeed, Z. A. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098288 · Cited by 257
A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia
Talley, N. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90007-8 · Cited by 249
Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
Rokkas, T., Karameris, A., Mavrogeorgis, A., Rallis, E., & Giannikos, N. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70266-0 · Cited by 231
Screening dyspepsia by serology to Helicobacter pylori
SOBALA, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90085-4 · Cited by 218
Classification and Grading of Gastritis: The Updated Sydney System
BEALL, D. P. (1997) · Radiology · doi:10.1148/radiology.203.2.434 · Cited by 191
Prospective screening of dyspeptic patients by Helicobacter pylori serology
Patel, P., Mendall, M. A., Khulusi, S., Lloyd, R., Jazrawi, R., Maxwell, J. D., & Northfield, T. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92340-3 · Cited by 170
Cited by
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Lind, T., Mégraud, F., Unge, P., Bayerdörffer, E., O'Morain, C., Spiller, R., van Zanten, S. V., Bardhan, K. D., Hellblom, M., Wrangstadh, M., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70119-8 · Cited by 434
Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
Liu, W. Z., Xie, Y., Lu, H., Cheng, H., Zeng, Z. R., Zhou, L. Y., Chen, Y., Wang, J. B., Du, Y. Q., Lu, N. H., et al. (2018) · Helicobacter · doi:10.1111/hel.12475 · Cited by 422
A Report Card to Grade Helicobacter pylori Therapy
Graham, D. Y., Lu, H., & Yamaoka, Y. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00518.x · Cited by 393
Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J. O., Berg, D. E., & Hoffman, P. S. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00806.x · Cited by 353
Metadata
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1997-07
- Volume
- 41
- Issue
- 1
- Pages
- 8-13
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W4237403611
- Cited by
- 787
- References
- 16
- FWCI
- 96.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. https://app.cochat.ai/papers/10.1136/gut.41.1.8
- The paper
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. (1997). Gut. https://doi.org/10.1136/gut.41.1.8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
